Free Trial
One Day Left! MarketBeat All Access Returns to $249 Soon
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Don't Miss Out
Claim MarketBeat All Access Sale Promotion

This company has been marked as potentially delisted and may not be actively trading.

NYSE:OMI

Owens & Minor (OMI) Stock Price, News & Analysis

Owens & Minor logo

About Owens & Minor Stock (NYSE:OMI)

Key Stats

Today's Range
$2.69
▼
$2.82
50-Day Range
$2.49
▼
$3.17
52-Week Range
$2.38
▼
$9.55
Volume
1.27 million shs
Average Volume
1.79 million shs
Market Capitalization
$223.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Owens & Minor, Inc. is a global healthcare solutions company specializing in the distribution of medical and surgical supplies, as well as supply chain management services. The company partners with healthcare providers, manufacturers and group purchasing organizations to deliver critical products and customized logistics solutions across the continuum of care. Its offerings range from standard medical-surgical products to specialized clinical devices, all supported by technology-driven inventory management and consulting services aimed at optimizing operational efficiency for hospitals, ambulatory surgery centers and other care facilities.

Founded in 1882 and headquartered in Mechanicsville, Virginia, Owens & Minor has evolved from a regional pharmaceutical distributor into a leader in healthcare logistics. Over its history, the company has expanded through strategic acquisitions and investments in supply chain technology. This evolution has allowed it to address the complex needs of a modern healthcare system, including the integration of data analytics, automated warehousing and customized transportation solutions.

Owens & Minor operates across two core segments: U.S. and International. In the United States, it maintains a network of distribution centers and service hubs that support acute care, alternate site and government healthcare channels. Its international segment serves customers in Europe and select Asia-Pacific markets, providing last-mile delivery, clinical consulting and market-specific product sourcing. The company’s global reach enables it to navigate diverse regulatory environments and supply chain challenges.

Led by President and Chief Executive Officer Edward Pesicka, Owens & Minor emphasizes continuous innovation in healthcare logistics. The leadership team combines expertise in supply chain engineering, clinical operations and digital transformation to address evolving industry demands. By aligning strategic partnerships, technology and service capabilities, the company aims to enhance patient outcomes and cost-effectively support healthcare providers worldwide.

AI Generated. May Contain Errors.

Owens & Minor Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
9th Percentile Overall Score

OMI MarketRank™: 
0.466090768435 of 5 stars

Owens & Minor scored higher than 9% of companies evaluated by MarketBeat, and ranked 865th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Owens & Minor has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Owens & Minor has received no research coverage in the past 90 days.

  • Read more about Owens & Minor's stock forecast and price target.
  • Earnings Growth

    Earnings for Owens & Minor are expected to grow by 16.56% in the coming year, from $1.51 to $1.76 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Owens & Minor is -0.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Owens & Minor is -0.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Owens & Minor has a P/B Ratio of 0.39. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for OMI.
  • Dividend Yield

    Owens & Minor does not currently pay a dividend.

  • Dividend Growth

    Owens & Minor does not have a long track record of dividend growth.

  • Search Interest

    1 people have searched for OMI on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Owens & Minor insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    3.69% of the stock of Owens & Minor is held by insiders.

  • Percentage Held by Institutions

    98.04% of the stock of Owens & Minor is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Owens & Minor's insider trading history.
Receive OMI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Owens & Minor and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OMI Stock News Headlines

Owens & Minor Earnings Call Flags Tough 2026
A free stock pick, from me to you
Elon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.tc pixel
See More Headlines

OMI Stock Analysis - Frequently Asked Questions

Owens & Minor, Inc. (NYSE:OMI) released its quarterly earnings results on Thursday, October, 30th. The company reported $0.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.23 by $0.02. The business's quarterly revenue was up 1.5% compared to the same quarter last year.
Read the conference call transcript
.

Owens & Minor's Board of Directors approved a share repurchase plan on Friday, February 28th 2025, which permits the company to repurchase $100 million in outstanding shares, according to EventVestor. This means that the company could buy up to 13.6% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's management believes its shares are undervalued.

The following companies are subsidiaries of Owens & Minor: Halyard Health - S&IP, Byram Healthcare Centers, ArcRoyal, Medical Action Industries, Movianto, The Burrows Company, McKesson's Acute-Care Medical, and others.

Based on aggregate information from My MarketBeat watchlists, some other companies that Owens & Minor investors own include Advanced Micro Devices (AMD), Pfizer (PFE), NVIDIA (NVDA), PayPal (PYPL), Tesla (TSLA), Cisco Systems (CSCO) and Alibaba Group (BABA).

Company Calendar

Last Earnings
10/30/2025
Today
10/29/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NYSE:OMI
CIK
75252
Employees
23,200
Year Founded
1882

Profitability

EPS (Trailing Twelve Months)
($17.40)
Trailing P/E Ratio
N/A
Forward P/E Ratio
1.92
P/E Growth
N/A
Net Income
-$362.69 million
Net Margins
-19.99%
Pretax Margin
-6.64%
Return on Equity
95.57%
Return on Assets
2.30%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.86
Quick Ratio
0.84

Sales & Book Value

Annual Sales
$10.77 billion
Price / Sales
0.02
Cash Flow
$9.34 per share
Price / Cash Flow
0.31
Book Value
$7.33 per share
Price / Book
0.39

Miscellaneous

Outstanding Shares
77,347,000
Free Float
74,493,000
Market Cap
$223.92 million
Optionable
Optionable
Beta
1.37

Social Links

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NYSE:OMI) was last updated on 12/31/2025 by MarketBeat.com Staff.
From Our Partners